Skip to main content
Year archive

Kintor Pharmaceutical Limited — 2023 filings

All 44 regulatory filings released by Kintor Pharmaceutical Limited (9939) in 2023, sourced directly from the official regulator.

44 Filings
2023 Period
2023 filings (44)
Filing Released Lang
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE BY CHAIRMAN OF THE BOARD, EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER
Director's Dealing
2023-12-20 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
Regulatory Filings
2023-12-01 English
INSIDE INFORMATION RESULTS OF KX-826 PHASE III CLINICAL TRIAL FOR TREATMENT OF MALE AGA IN CHINA
Regulatory Filings
2023-11-27 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
Regulatory Filings
2023-11-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
Regulatory Filings
2023-10-04 English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE 2022 ANNUAL REPORT AND THE 2023 INTERIM REPORT
Report Publication Announcement
2023-09-28 English
Notification Letter to Non-registered holders - Notice of Publication of 2023 Interim Report and Request Form
Report Publication Announcement
2023-09-27 English
INTERIM REPORT 2023
Interim / Quarterly Report
2023-09-27 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
Regulatory Filings
2023-09-04 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023
Interim / Quarterly Report
2023-08-28 English
VOLUNTARY ANNOUNCEMENT - COMPLETION OF PATIENT ENROLLMENT IN PHASE II CLINICAL TRIAL OF GT20029 FOR TREATMENT OF ANDROGENETIC ALOPECIA IN CHINA
Regulatory Filings
2023-08-22 English
DATE OF BOARD MEETING
Report Publication Announcement
2023-08-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
Regulatory Filings
2023-08-01 English
VOLUNTARY ANNOUNCEMENT - COMPLETION OF FIRST PATIENT ENROLLMENT IN LONG-TERM SAFETY PHASE III TRIAL OF KX-826 FOR TREATMENT OF AGA
Regulatory Filings
2023-07-19 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
Share Issue/Capital Change
2023-07-03 English
AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Governance Information
2023-06-15 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 15 JUNE 2023
Declaration of Voting Results & Voting Rights Announcements
2023-06-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
Share Issue/Capital Change
2023-06-02 English
APPOINTMENT OF JOINT COMPANY SECRETARY WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES AND CHANGE OF PROCESS AGENT
Board/Management Information
2023-05-12 English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING
AGM Information
2023-05-12 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2023-05-12 English
Notification Letter to Non-registered holders - Notice of Publication of Circular and Notice of Annual General Meeting and Request Form
Report Publication Announcement
2023-05-12 English
(1) RE-ELECTION OF RETIRING DIRECTORS&#x3b; (2) RE-APPOINTMENT OF AUDITOR&#x3b; (3) GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES&#x3b; (4) PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND
AGM Information
2023-05-12 English
VOLUNTARY ANNOUNCEMENT - SUCCESSFUL COMPLETION OF PHASE II CLINICAL TRIAL OF KX-826 FOR TREATMENT OF AGA IN THE UNITED STATES
Regulatory Filings
2023-05-11 English
VOLUNTARY ANNOUNCEMENT - SUCCESSFUL COMPLETION OF PHASE I CLINICAL TRIAL OF GT1708F FOR TREATMENT OF HEMATOLOGIC MALIGNANCIES IN CHINA
Regulatory Filings
2023-05-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
Regulatory Filings
2023-05-02 English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2022
Environmental & Social Information
2023-04-28 English
Notification Letter to Non-registered holders - Notice of Publication of 2022 Annual Report and Request Form
Report Publication Announcement
2023-04-28 English
ANNUAL REPORT 2022
Regulatory Filings
2023-04-28 English
VOLUNTARY ANNOUNCEMENT - COMPLETION OF FIRST SUBJECT ENROLLMENT IN PHASE II CLINICAL TRIAL OF AR-PROTAC(GT20029) FOR TREATMENT OF ANDROGENETIC ALOPECIA IN CHINA
Regulatory Filings
2023-04-14 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2023-04-14 English
(1) CHANGE IN EXECUTIVE DIRECTORS&#x3b; (2) CHANGE IN CHIEF FINANCIAL OFFICER&#x3b; AND (3) CHANGE IN JOINT COMPANY SECRETARY
Board/Management Information
2023-04-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
Regulatory Filings
2023-04-04 English
TERMS OF REFERENCE OF THE AUDIT COMMITTEE
Governance Information
2023-03-31 English
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE
Governance Information
2023-03-31 English
TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE
Remuneration Information
2023-03-31 English
(1) ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2022&#x3b; (2) PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION&#x3b; AND (3) PROPOSED INCREASE IN AUTHORISED SHARE CAPI
Annual Report
2023-03-30 English
VOLUNTARY ANNOUNCEMENT - COMPLETION OF ENROLLMENT OF SUBJECTS IN PHASE III CLINICAL TRIAL OF KX-826 FOR TREATMENT OF MALE AGA IN CHINA
Regulatory Filings
2023-03-28 English
CHANGE IN USE OF PROCEEDS AND THE RESULTS OF PHASE III CLINICAL TRIAL OF PRUXELUTAMIDE MONOTHERAPY FOR THE TREATMENT OF PROSTATE CANCER
Capital/Financing Update
2023-03-28 English
DATE OF BOARD MEETING
Report Publication Announcement
2023-03-16 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023
Major Shareholding Notification
2023-03-01 English
VOLUNTARY ANNOUNCEMENT TOP-LINE RESULTS OF PHASE I CLINICAL TRIAL OF GT20029 IN THE U.S.
Regulatory Filings
2023-02-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023
Regulatory Filings
2023-02-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022
Regulatory Filings
2023-01-03 English